Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
62 | MeReC Extra | journal | 0.101 Q4 | 2 | 9 | 21 | 26 | 1 | 16 | 0.07 | 2.89 | |
61 | Drugs and Therapy Perspectives | journal | 0.102 Q4 | 13 | 84 | 266 | 1379 | 5 | 236 | 0.02 | 16.42 | |
60 | Therapy | journal | 0.107 Q4 | 22 | 99 | 37 | 5214 | 8 | 34 | 0.22 | 52.67 | |
59 | Pharmaceutical Medicine | journal | 0.108 Q4 | 25 | 43 | 81 | 829 | 8 | 59 | 0.08 | 19.28 | |
58 | Klinik Psikofarmakoloji Bulteni | journal | 0.124 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
57 | MeReC Bulletin | journal | 0.143 Q3 | 7 | 1 | 21 | 18 | 9 | 21 | 0.25 | 18.00 | |
56 | Journal of Oncology Pharmacy Practice | journal | 0.144 Q3 | 44 | 24 | 50 | 600 | 16 | 46 | 0.40 | 25.00 | |
55 | AIDS Research and Therapy | journal | 0.167 Q3 | 49 | 12 | 2 | 348 | 2 | 1 | 1.00 | 29.00 | |
54 | PharmacoEconomics - Italian Research Articles | journal | 0.169 Q3 | 9 | 18 | 38 | 461 | 22 | 38 | 0.63 | 25.61 | |
53 | Pharmacy in Practice | journal | 0.170 Q3 | 6 | 85 | 134 | 515 | 13 | 111 | 0.12 | 6.06 | |
52 | Clinical Pharmacist | journal | 0.186 Q3 | 11 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
51 | Journal of Clinical Research | journal | 0.188 Q3 | 12 | 4 | 5 | 55 | 2 | 5 | 0.67 | 13.75 | |
50 | Expert Review of Neurotherapeutics | journal | 0.202 Q3 | 98 | 94 | 291 | 5921 | 152 | 276 | 0.56 | 62.99 | |
49 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.205 Q3 | 61 | 84 | 233 | 3630 | 98 | 198 | 0.43 | 43.21 | |
48 | Clinical Drug Investigation | journal | 0.252 Q3 | 67 | 90 | 280 | 2518 | 255 | 272 | 0.98 | 27.98 | |
47 | BMC Clinical Pharmacology | journal | 0.266 Q3 | 43 | 6 | 18 | 137 | 27 | 18 | 1.70 | 22.83 | |
46 | Drug and Therapeutics Bulletin | journal | 0.317 Q3 | 17 | 28 | 97 | 745 | 63 | 93 | 0.76 | 26.61 | |
45 | Advances in Antiviral Drug Design | book series | 0.347 Q2 | 12 | 0 | 7 | 0 | 6 | 7 | 0.86 | 0.00 | |
44 | Pharmaceutical Statistics | journal | 0.391 Q2 | 46 | 31 | 32 | 410 | 23 | 28 | 0.72 | 13.23 | |
43 | Journal of Chemotherapy | journal | 0.401 Q2 | 56 | 115 | 399 | 3127 | 518 | 365 | 1.20 | 27.19 | |
42 | Biopharmaceutics and Drug Disposition | journal | 0.403 Q2 | 65 | 51 | 136 | 1173 | 191 | 136 | 1.33 | 23.00 | |
41 | European Journal of Contraception and Reproductive Health Care | journal | 0.403 Q2 | 53 | 46 | 115 | 983 | 121 | 115 | 1.11 | 21.37 | |
40 | Acta Pharmacologica Sinica | journal | 0.468 Q2 | 117 | 221 | 693 | 6998 | 1006 | 692 | 1.53 | 31.67 | |
39 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.488 Q2 | 81 | 87 | 208 | 2151 | 335 | 197 | 1.52 | 24.72 | |
38 | Expert Opinion on Emerging Drugs | journal | 0.570 Q2 | 54 | 53 | 88 | 6214 | 194 | 86 | 2.83 | 117.25 | |
37 | Expert Review of Anticancer Therapy | journal | 0.583 Q2 | 85 | 108 | 323 | 7186 | 530 | 288 | 1.81 | 66.54 | |
36 | Fundamental and Clinical Pharmacology | journal | 0.586 Q2 | 85 | 77 | 213 | 3234 | 456 | 211 | 2.17 | 42.00 | |
35 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 242 | 594 | 16676 | 1479 | 582 | 2.47 | 68.91 | |
34 | Expert Opinion on Drug Safety | journal | 0.616 Q2 | 90 | 93 | 149 | 7544 | 341 | 145 | 2.04 | 81.12 | |
33 | Paediatric Drugs | journal | 0.620 Q2 | 70 | 32 | 180 | 3071 | 474 | 171 | 2.69 | 95.97 | |
32 | Human Psychopharmacology | journal | 0.646 Q2 | 86 | 69 | 240 | 2281 | 502 | 221 | 1.98 | 33.06 | |
31 | BioDrugs | journal | 0.649 Q2 | 79 | 35 | 137 | 3137 | 357 | 133 | 2.30 | 89.63 | |
30 | American Journal of Cardiovascular Drugs | journal | 0.657 Q2 | 60 | 40 | 143 | 3146 | 282 | 133 | 1.94 | 78.65 | |
29 | International Journal of STD and AIDS | journal | 0.661 Q2 | 78 | 240 | 642 | 3638 | 777 | 513 | 1.08 | 15.16 | |
28 | BMC Pharmacology | journal | 0.670 Q2 | 48 | 17 | 69 | 548 | 136 | 69 | 1.77 | 32.24 | |
27 | British Journal of Clinical Pharmacology, Supplement | journal | 0.706 Q2 | 33 | 0 | 27 | 0 | 110 | 25 | 3.56 | 0.00 | |
26 | Trials | journal | 0.730 Q2 | 98 | 18 | 24 | 763 | 36 | 24 | 0.93 | 42.39 | |
25 | Pharmacoepidemiology and Drug Safety | journal | 0.760 Q2 | 109 | 121 | 324 | 2913 | 544 | 271 | 1.62 | 24.07 | |
24 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.774 Q1 | 69 | 67 | 260 | 1779 | 642 | 256 | 2.26 | 26.55 | |
23 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.777 Q1 | 57 | 43 | 130 | 1472 | 254 | 117 | 1.87 | 34.23 | |
22 | Drugs and Aging | journal | 0.812 Q1 | 109 | 86 | 237 | 6446 | 713 | 222 | 3.07 | 74.95 | |
21 | HIV Clinical Trials | journal | 0.903 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
20 | Journal of Psychopharmacology | journal | 0.956 Q1 | 135 | 120 | 218 | 4648 | 617 | 194 | 2.95 | 38.73 | |
19 | Journal of Biomedical Science | journal | 0.979 Q1 | 110 | 87 | 268 | 3760 | 642 | 266 | 2.31 | 43.22 | |
18 | British Journal of Clinical Pharmacology | journal | 1.038 Q1 | 167 | 208 | 623 | 4715 | 1933 | 526 | 2.94 | 22.67 | |
17 | Drug Safety | journal | 1.053 Q1 | 140 | 86 | 272 | 5982 | 1158 | 258 | 4.11 | 69.56 | |
16 | Expert Opinion on Investigational Drugs | journal | 1.059 Q1 | 117 | 137 | 423 | 11445 | 1588 | 412 | 3.61 | 83.54 | |
15 | Cochrane Database of Systematic Reviews | journal | 1.101 Q1 | 327 | 493 | 1256 | 32112 | 5450 | 1256 | 4.35 | 65.14 | |
14 | CNS Drugs | journal | 1.245 Q1 | 129 | 85 | 263 | 6860 | 1199 | 245 | 4.26 | 80.71 | |
13 | Drugs | journal | 1.324 Q1 | 188 | 195 | 604 | 16302 | 3091 | 511 | 5.17 | 83.60 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®